<?xml version='1.0' encoding='UTF-8'?><metadata xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns="http://dublincore.org/documents/dcmi-terms/"><dcterms:title>Single Incision Device (TVT Secur) Versus Retropubic Tension-free Vaginal Tape Device (TVT) for the Management of Stress Urinary Incontinence in Women: A Randomized Clinical Trial</dcterms:title><dcterms:identifier>https://doi.org/10.7939/DVN/10962</dcterms:identifier><dcterms:creator>Ross, Sue</dcterms:creator><dcterms:creator>Tang, Selphee</dcterms:creator><dcterms:creator>Schulz, Jane</dcterms:creator><dcterms:creator>Murphy, Magnus</dcterms:creator><dcterms:creator>Goncalves, Jose</dcterms:creator><dcterms:creator>Kaye, Stephen</dcterms:creator><dcterms:creator>Dederer, Lorel</dcterms:creator><dcterms:creator>Robert, Magali</dcterms:creator><dcterms:publisher>UAL Dataverse</dcterms:publisher><dcterms:issued>2016-12-05</dcterms:issued><dcterms:modified>2017-05-29T19:39:53Z</dcterms:modified><dcterms:description>The objective of this Canadian multi-centre pragmatic randomized controlled trial was to compare the effectiveness of the new single-incision device, Gynecare TVT Secur, to the established predecate retropubic TVT device, in terms of objective cure of stress urinary incontinence (SUI) at 12 months postoperatively. Other outcomes included: complications, symptoms, and incontinence-related quality of life.</dcterms:description><dcterms:subject>Medicine, Health and Life Sciences</dcterms:subject><dcterms:subject>single incision device</dcterms:subject><dcterms:subject>stress urinary incontinence</dcterms:subject><dcterms:subject>surgical treatment</dcterms:subject><dcterms:subject>effectiveness</dcterms:subject><dcterms:subject>randomized controlled trial</dcterms:subject><dcterms:isReferencedBy>Ross S, Tang S, Schulz J, et al. Single incision device (TVT Secur) versus retropubic tension-free vaginal tape device (TVT) for the management of stress urinary incontinence in women: a randomized clinical trial. BMC Research Notes. 2014;7:941., doi, 10.1186/1756-0500-7-941, https://www.ncbi.nlm.nih.gov/pubmed/25532604</dcterms:isReferencedBy><dcterms:date>2008</dcterms:date><dcterms:temporal>2008-05</dcterms:temporal><dcterms:temporal>2012-04</dcterms:temporal><dcterms:temporal>2008-05</dcterms:temporal><dcterms:temporal>2011-03</dcterms:temporal><dcterms:type>Questionnaire data; Clinical data</dcterms:type><dcterms:source>Urogenital Distress Inventory (UDI-6); Incontinence Impact Questionnaire (IIQ-7); the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire-12, (PISQ-12); the 15D Instrument of Health-related Quality of Life (15D) was included for the proposed economic evaluation which was never done.</dcterms:source><dcterms:spatial>Canada</dcterms:spatial><dcterms:spatial>Calgary, Alberta; Edmonton, Alberta; Vancouver, British Columbia; Penticton, British Columbia</dcterms:spatial><dcterms:license>NONE</dcterms:license></metadata>